NeuroOne Medical (NMTC) Technologies announced that Clara – an early patient treated with the Company’s patented OneRF Ablation System – has successfully surpassed the one year milestone of being seizure free. “This milestone further validates the intended benefits of our OneRF platform. Our next step is to leverage the technology for other applications, including our OneRF Trigeminal Nerve Ablation System to treat facial pain, for which we filed a 510(k) submission to the FDA in April 2025,” said Dave Rosa, CEO of NeuroOne.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMTC: